DocGo’s (DCGO) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of DocGo (NASDAQ:DCGOFree Report) in a research report released on Thursday morning,Benzinga reports. Needham & Company LLC currently has a $7.00 price objective on the stock.

Separately, Cantor Fitzgerald reissued an “overweight” rating and set a $5.00 target price on shares of DocGo in a research report on Friday, September 20th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $6.10.

Get Our Latest Stock Analysis on DocGo

DocGo Stock Down 2.3 %

DCGO opened at $4.17 on Thursday. DocGo has a fifty-two week low of $2.75 and a fifty-two week high of $4.86. The business has a fifty day simple moving average of $4.23 and a 200-day simple moving average of $3.69. The firm has a market cap of $425.55 million, a PE ratio of 14.89, a P/E/G ratio of 11.49 and a beta of 0.97.

Insider Activity

In other DocGo news, General Counsel Ely D. Tendler sold 23,088 shares of the firm’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $4.44, for a total value of $102,510.72. Following the completion of the sale, the general counsel now owns 175,645 shares of the company’s stock, valued at approximately $779,863.80. This trade represents a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 2.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On DocGo

Hedge funds and other institutional investors have recently made changes to their positions in the stock. SG Americas Securities LLC increased its stake in DocGo by 12.9% in the fourth quarter. SG Americas Securities LLC now owns 43,052 shares of the company’s stock valued at $183,000 after acquiring an additional 4,905 shares during the last quarter. Harbor Capital Advisors Inc. lifted its holdings in DocGo by 37.5% in the fourth quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company’s stock worth $5,647,000 after buying an additional 363,391 shares during the period. JPMorgan Chase & Co. boosted its position in shares of DocGo by 151.1% during the third quarter. JPMorgan Chase & Co. now owns 109,855 shares of the company’s stock valued at $365,000 after purchasing an additional 66,097 shares in the last quarter. Franklin Resources Inc. lifted its position in DocGo by 11.6% during the third quarter. Franklin Resources Inc. now owns 1,199,086 shares of the company’s stock valued at $3,933,000 after buying an additional 124,348 shares during the period. Finally, Barclays PLC lifted its holdings in shares of DocGo by 279.7% during the third quarter. Barclays PLC now owns 134,923 shares of the company’s stock valued at $447,000 after purchasing an additional 99,387 shares during the last quarter. 56.44% of the stock is owned by hedge funds and other institutional investors.

About DocGo

(Get Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Featured Articles

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.